An Open Dose-finding Study of Oral Applied Hexaminolevulinate (HAL) Imaging in Patients With Suspicion or High Risk of Neoplasia in the Colon

NCT01344902 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
13
Enrollment
INDUSTRY
Sponsor class

Stopped The study was stopped due to inadequate efficacy after 13 patients were evaluated.

Conditions

Interventions

Sponsor

Photocure